Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovaprevir + Peg-IFN + Ribavirin in Chronic HCV Genotype 1
NCT01180790Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Sep 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules, Modified Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of sovaprevir in hepatitis C (HCV), sponsored by Alexion Pharmaceuticals. Started Sep 2010; status: completed.
02
Drugs
sovaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01180790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01180790.